Evado launches into Asia
Wednesday, 22 October, 2008
Melbourne company Evado has launched its clinical trial software into the growing south-east Asian market.
Evado is being distributed by local clinical research company SeerPharma.
Evado is a web-based mobile electronic data capture (EDC) system with two modules, one aimed at pre-clinical animal model trials and the other a clinical module for Phases I to IV.
It was developed in association with La Trobe University software researchers working at the university’s Microsoft Centre, along with Intel.
Evado CEO Jennie Anderson said the software was designed so that researchers can collect data on larger screens in a format similar to paper-based clinical research forms.
Novel antibiotic activates 'suicide' mechanism in superbug
Researchers have discovered a new class of antibiotic that selectively targets Neisseria...
Modifications in the placenta linked to psychiatric disorders
Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...
ADHD may be linked with an increased risk of dementia
An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...